Found: 24
Select item for more details and to access through your institution.
SARS-COV-2 vaccine responses in renal patient populations.
- Published in:
- BMC Nephrology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12882-022-02792-w
- By:
- Publication type:
- Article
Avacopan for ANCA-associated vasculitis – information for prescribers.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1067, doi. 10.1093/ndt/gfac330
- By:
- Publication type:
- Article
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 4, p. 599, doi. 10.1093/ndt/gfz086
- By:
- Publication type:
- Article
Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 3, p. 1, doi. 10.1093/rap/rkae090
- By:
- Publication type:
- Article
Progress in treatment of ANCA-associated vasculitis.
- Published in:
- Arthritis Research & Therapy, 2012, v. 14, n. 2, p. 210, doi. 10.1186/ar3797
- By:
- Publication type:
- Article
Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07218-y
- By:
- Publication type:
- Article
IgA vasculitis (Henoch–Schönlein purpura): refractory and relapsing disease course in the adult population.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 8, p. 1953, doi. 10.1093/ckj/sfaa251
- By:
- Publication type:
- Article
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.
- Published in:
- Clinical Kidney Journal, 2014, v. 7, n. 6, p. 562, doi. 10.1093/ckj/sfu096
- By:
- Publication type:
- Article
Deciphering neurological symptoms in ANCA-associated vasculitis, uncontrolled disease or a complication of therapy.
- Published in:
- Rheumatology, 2021, v. 60, p. iii67, doi. 10.1093/rheumatology/keab103
- By:
- Publication type:
- Article
Therapeutic dilemmas in relapsing renal ANCA-associated vasculitis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Aggressive vasculitis after lung transplantation for cystic fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Fever on an airline flight: a diagnostic challenge.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Pregnancy following rituximab for orbital eosinophilic angiocentric fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models.
- Published in:
- Rheumatology, 2021, v. 60, n. 3, p. 1491, doi. 10.1093/rheumatology/keaa541
- By:
- Publication type:
- Article
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines—Executive summary.
- Published in:
- Rheumatology, 2020, v. 59, n. 4, p. 727, doi. 10.1093/rheumatology/kez632
- By:
- Publication type:
- Article
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.
- Published in:
- Rheumatology, 2020, v. 59, n. 4, p. e24, doi. 10.1093/rheumatology/kez640
- By:
- Publication type:
- Article
novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1153, doi. 10.1093/rheumatology/keu452
- By:
- Publication type:
- Article
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 10, p. 1670, doi. 10.1002/art.40932
- By:
- Publication type:
- Article
Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
- Published in:
- Nephrology Dialysis Transplantation, 2010, v. 25, n. 11, p. 3586, doi. 10.1093/ndt/gfq256
- By:
- Publication type:
- Article
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.
- Published in:
- BMC Musculoskeletal Disorders, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1471-2474-15-178
- By:
- Publication type:
- Article
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article